Skip to Main Content

Paper Details

Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway.
Nat Genet
182
2015
293 genes, BRAF, CBL, Desmoplastic melanoma, EGFR, ERBB2, Gln61Arg, IB, MAP2K1, MAP3K1, MAPK, MET, NF-B inhibitor, NF1, NFKBIE, NFKBIE promoter, NRAS, PI3K, PIK3CA, PTPN11, RAC1, SOS2, cancers, desmoplastic melanoma, desmoplastic melanomas, melanoma, melanomas, p.Gln61Arg, p.Gln61Lys, p.Val600Glu
Author NameAffiliation
John Z Sanborn
Ritu RoyHelen Diller Family Comprehensive Cancer Center
Adam B OlshenHelen Diller Family Comprehensive Cancer Center
Adam B OlshenUniversity of California san francisco
Joe W GrayOregon Health and Sciences University
Joe W GrayKnight Cancer Institute, Oregon Health and Sciences University
Joe W GrayOregon Health and Sciences University
Joe W GrayKnight Cancer Institute, Oregon Health and Sciences University
Richard A ScolyerMelanoma Institute Australia
Richard A ScolyerRoyal Prince Alfred Hospital
Richard A ScolyerSydney Medical School, University of Sydney
Raymond J ChoUniversity of California san francisco
  • 1 - 12

Datasets

Release 1.2